Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington’s disease

No abstract is available for this paper.

• Publication year

  2019

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2019-01-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-018-4257-zPMID 30627816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters

  2019cited by this paper
• Structural and functional changes of the visual cortex in early Huntington's disease

  2018cited by this paper
• Improved metrics for Huntington’s disease trials

  2018cited by this paper
• Effect of Memantine on Brain Metabolic Activity and Perfusion in Drug-naïve Moderate Alzheimer’s DiseasePatients

  2018cited by this paper
• Structural and metabolic brain correlates of apathy in Huntington's disease

  2018cited by this paper
• Structural imaging in premanifest and manifest Huntington disease.

  2017cited by this paper
• Current status of PET imaging in Huntington’s disease

  2016cited by this paper
• Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging

  2016cited by this paper
• Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington’s Disease

  2016cited by this paper
• Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.

  2016cited by this paper
• Striatal hypometabolism in premanifest and manifest Huntington’s disease patients

  2016cited by this paper
• The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease.

  2015cited by this paper
• Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data

  2014cited by this paper
• Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

  2012cited by this paper
• Huntington's disease: effect of memantine on FDG-PET brain metabolism?

  2011cited by this paper
• Huntington's disease: from molecular pathogenesis to clinical treatment

  2011cited by this paper
• Cerebral cortex structure in prodromal Huntington disease.

  2010cited by this paper
• EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

  2009cited by this paper
• Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

  2009cited by this paper
• Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.

  2008cited by this paper
• Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.

  2008cited by this paper
• Regional and progressive thinning of the cortical ribbon in Huntington’s disease

  2002cited by this paper
• Measuring the thickness of the human cerebral cortex from magnetic resonance images.

  2000cited by this paper
• Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study

  1992cited by this paper

• Neurodegenerative Disease Movement Disorders and Dorsal Striatum-Mediated Imbalance of Habitual Motor Sequences

  2025cites this paper
• Update on Genetic Chorea

  2025cites this paper
• Mild cognitive impairment in Huntington’s disease: challenges and outlooks

  2024cites this paper
• Cortical changes in the brain of patients with hemifacial spasm

  2024cites this paper
• Structural and metabolic brain correlates of arithmetic word‐problem solving in Huntington's disease

  2023cites this paper
• [18F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review

  2023cites this paper
• Characteristics and Clinical Implication of White Matter Lesions in Patients With Adult Moyamoya Disease

  2023cites this paper
• Histological Study on the Thickness of Gray Matter at the Summit and Bottom of Folium in Different Age Groups of Bangladeshi People

  2023cites this paper
• Pearls and Oy-sters: Huntington Disease Presenting as Primary Progressive Aphasia: A Case of Semantics.

  2023cites this paper
• Obsessive-Compulsive and Perseverative Behaviors in Huntington's Disease.

  2023cites this paper
• Frequency and Pathophysiology of Apathy in Huntington Disease: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Delineating apathy profiles in Huntington's disease with the short-Lille Apathy Rating Scale.

  2022cites this paper
• Multimodal Imaging and Visual Evoked Potentials Reveal Key Structural and Functional Features That Distinguish Symptomatic From Presymptomatic Huntington's Disease Brain

  2021cites this paper
• Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington’s Disease

  2021cites this paper
• Autoscopic phenomena as an atypical psychiatric presentation of Huntington's disease: A case report including longitudinal clinical and neuroimaging data.

  2020cites this paper
• Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease

  2020cites this paper
• Increased cerebral FDG‐PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia

  2020cites this paper